Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-3.67
Operating CF/Share$-2.95
Free CF/Share$-2.33
Cash/Share$5.64
Book Value/Share$7.65
Tangible Book/Share$7.65
Equity/Share$7.65
Interest Debt/Share$0.02
CapEx/Share$0.62
Dividend/Share$0.00
Valuation
Market Cap$706.55M
Enterprise Value$604.41M
P/E Ratio-3.26P/S Ratio0.00P/OCF Ratio-4.05
P/FCF Ratio-5.14
P/B Ratio1.56P/TB Ratio1.56
EV/Sales0.00EV/EBITDA-2.56
Graham Valuation
Graham Number--
Graham Net-Net$5.08
Profitability
Earnings Yield-30.72%FCF Yield-19.45%ROE-41.58%ROIC-53.35%Return on Tangible Assets-44.78%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-21.16%
CapEx/Revenue0.00%
CapEx/Depreciation119.34
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00Debt/Market Cap0.00
Net Debt/EBITDA0.43
Current Ratio10.45Interest Coverage0.00xIncome Quality0.80Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$451.37M
Working Capital$309.48M
Invested Capital$311.01M
Intangibles/Assets0.00%